However, FDA rejected suggestions that low-risk devices be exempted because the cost of implementation will exceed the public health benefits gained.
The cost of implementation is quite high.
mnli hypothesis: The cost of implementation is quite high. premise: However, FDA rejected suggestions that low-risk devices be exempted because the cost of implementation will exceed the public health benefits gained.